JP2003000270A5 - - Google Patents

Download PDF

Info

Publication number
JP2003000270A5
JP2003000270A5 JP2001306811A JP2001306811A JP2003000270A5 JP 2003000270 A5 JP2003000270 A5 JP 2003000270A5 JP 2001306811 A JP2001306811 A JP 2001306811A JP 2001306811 A JP2001306811 A JP 2001306811A JP 2003000270 A5 JP2003000270 A5 JP 2003000270A5
Authority
JP
Japan
Prior art keywords
peptide
polynucleotide
recombinant vector
complementary strand
transformant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001306811A
Other languages
English (en)
Japanese (ja)
Other versions
JP4097178B2 (ja
JP2003000270A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001306811A priority Critical patent/JP4097178B2/ja
Priority claimed from JP2001306811A external-priority patent/JP4097178B2/ja
Publication of JP2003000270A publication Critical patent/JP2003000270A/ja
Publication of JP2003000270A5 publication Critical patent/JP2003000270A5/ja
Application granted granted Critical
Publication of JP4097178B2 publication Critical patent/JP4097178B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001306811A 2000-10-03 2001-10-02 腫瘍抗原 Expired - Lifetime JP4097178B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001306811A JP4097178B2 (ja) 2000-10-03 2001-10-02 腫瘍抗原

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-304155 2000-10-03
JP2000304155 2000-10-03
JP2001-121452 2001-04-19
JP2001121452 2001-04-19
JP2001306811A JP4097178B2 (ja) 2000-10-03 2001-10-02 腫瘍抗原

Publications (3)

Publication Number Publication Date
JP2003000270A JP2003000270A (ja) 2003-01-07
JP2003000270A5 true JP2003000270A5 (enExample) 2005-06-23
JP4097178B2 JP4097178B2 (ja) 2008-06-11

Family

ID=27344853

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001306811A Expired - Lifetime JP4097178B2 (ja) 2000-10-03 2001-10-02 腫瘍抗原

Country Status (1)

Country Link
JP (1) JP4097178B2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1608756B1 (en) * 2003-03-31 2009-11-18 Intercell AG Staphylococcus epidermidis antigens
JP4579581B2 (ja) * 2003-12-08 2010-11-10 株式会社グリーンペプタイド 副甲状腺ホルモン関連タンパク質のｈｌａ−ａ２４またはｈｌａ−ａ２結合ペプチド
ES2390967T3 (es) 2004-01-20 2012-11-20 Aichi Prefecture Epítopo/péptido reconocido por LTC específico para Ep-CAM con restricción por ALH-A2402 y su utilización
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
CA2655042A1 (en) 2006-07-12 2008-01-17 Oncotx, Inc. Compositions and methods for targeting cancer-specific transcription complexes
ES2714200T3 (es) 2007-09-18 2019-05-27 Brightpath Biotherapeutics Co Ltd Composición inductora de CTL
WO2012005161A1 (ja) 2010-07-07 2012-01-12 株式会社グリーンペプタイド がんペプチドワクチン
WO2013130188A1 (en) * 2012-03-02 2013-09-06 Rhode Island Hospital, A Lifespan-Partner Treating human immunodeficiency virus infections
CN105008399B (zh) 2013-03-08 2018-09-28 大鹏药品工业株式会社 新型的具有5个连接的ctl表位的肽
HUE050164T2 (hu) * 2013-10-21 2020-12-28 Taiho Pharmaceutical Co Ltd Új négy-CTL epitóp-kapcsolt peptid
EP3815711A4 (en) 2018-06-29 2022-08-10 Taiho Pharmaceutical Co., Ltd. ANTITUMORS AGENTS AND METHODS OF EVALUATION THEREOF
EP4082563A4 (en) 2019-12-26 2024-02-28 Taiho Pharmaceutical Co., Ltd. POST-OPERATIVE ADJUVANT THERAPY AGENT

Similar Documents

Publication Publication Date Title
ES2582459T3 (es) Composiciones de variantes de fenilalanina amoníaco-liasa de procariotas y métodos de uso de sus composiciones
RU2001134170A (ru) Антигенные пептиды NEISSERIA
DE2967652D1 (en) Recombinant dna, hosts transformed with it and polypeptides produced by the hosts; processes for their preparation; detection processes using the polypeptides; compositions and means containing the polypeptides; dna sequences
EP2368907A3 (en) Anti-Abeta antibodies and their use
RU2002113920A (ru) Антигенные пептиды neisseria
CA2417570A1 (en) Tumor-specific t cell activation by peptide antigens
DE60041265D1 (de) Verwendung eines polypeptids zur auffindung von multipler sklerose
RU2007139915A (ru) Haemophilus influenzae типа в
EP2292647A3 (en) Small Streptococcus pyogenes antigens and their use
IL93397A (en) Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens
JP2002517193A5 (enExample)
WO2001096527A3 (en) Peptides with physiological activity
WO2007064844A3 (en) Anti-viral griffithsin compounds, compositions, and methods of use
CA2338886A1 (en) Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
JP2005510211A5 (enExample)
SE9901601D0 (sv) Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus
RU2007106900A (ru) Иммуногенные комплексы, способ их приготовления и их применение в фармацевтических композициях
JP2005524387A5 (enExample)
RU2010139769A (ru) Фармацевтическая композиция для трансназального введения
EP1439229A3 (en) Oncogene, recombinant protein derived therefrom, and uses thereof
WO2008029138A3 (en) Peptides and methods
DE602005019421D1 (de) Grosstechnisch geeigneter mikroorganismus
CA2311646A1 (en) Tsa305 gene
JP2002335976A5 (enExample)
WO2003051913A3 (en) Antigens for actinobacillus pleuropneumoniae and methods thereof